CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Mainolfi Nello Chief Executive Officer | Option exercise 10b5-1 | +30,000 | $2.08 | $62K | 696,568 |
| 2026-10-01 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −3,525 | $111.44 | $393K | 693,043 |
| 2026-10-01 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −5,506 | $112.42 | $619K | 687,537 |
| 2026-10-01 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −4,876 | $113.24 | $552K | 682,661 |
| 2026-10-01 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −7,601 | $114.43 | $870K | 675,060 |
| 2026-10-01 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −8,230 | $115.40 | $950K | 666,830 |
| 2026-10-01 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −262 | $116.12 | $30K | 666,568 |
| 2026-10-01 | Mainolfi Nello Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 60,000 | ||
| 2026-09-04 | Adams Brian Chief Legal Officer | Sale | −1,209 | $115.55 | $140K | 55,416 |
| 2026-09-04 | Adams Brian Chief Legal Officer | Sale | −3,025 | $116.81 | $353K | 52,391 |
| 2026-09-04 | Adams Brian Chief Legal Officer | Sale | −2,137 | $117.57 | $251K | 50,254 |
| 2026-07-27 | Rooney Terence Chief Medical Officer | Grant or award | +38,000 | 38,000 | ||
| 2026-07-27 | Rooney Terence Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +76,000 | 76,000 | ||
| 2026-07-07 | Mainolfi Nello Chief Executive Officer | Option exercise 10b5-1 | +50,000 | $2.08 | $104K | 716,568 |
| 2026-07-07 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −50,000 | $119.00 | $6.0M | 666,568 |
| 2026-07-07 | Mainolfi Nello Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −45,559 | 90,000 | ||
| 2026-07-07 | Mainolfi Nello Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,441 | 14,284 | ||
| 2026-07-01 | Goodman Noah Chief Business Officer | Sale 10b5-1 | −3,389 | $114.29 | $387K | 47,179.44 |
| 2026-07-01 | Mainolfi Nello Chief Executive Officer | Option exercise 10b5-1 | +80,000 | $2.08 | $166K | 746,568 |
| 2026-07-01 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −1,883 | $112.80 | $212K | 744,685 |
Page 1 of 25 · 493 trades